The tumor‐bearing mice treated with IgG demonstrate rapid tumor growth, while mice treated with anti‐TIM3 mAb showed a decreased rate of tumor growth as seen from tumor volumes in anti‐TIM3 group, which was significantly smaller than control group on days 30, 35, and 40 (Fig. 5B,C). This evidence concerns the gene HAVCR2 and neoplasm.